Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)

PHASE3CompletedINTERVENTIONAL
Enrollment

173

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2009

Study Completion Date

February 28, 2010

Conditions
Fatty Liver
Interventions
DRUG

Metformin

500 mg, twice daily

DIETARY_SUPPLEMENT

Vitamin E

400 IU, twice daily

DRUG

Matching placebo

Twice daily

Trial Locations (10)

20010

Children's National Medical Center, Washington D.C.

21205

Johns Hopkins University, Baltimore

23298

Virginia Commonwealth University, Richmond

44109

Case Western Reserve University, Cleveland

46202

Indiana University, Indianapolis

63110

St. Louis University, St Louis

77030

Texas Children's Hospital, Houston

92103

University of California, San Diego, San Diego

94143

University of California, San Francisco, San Francisco

98195

University of Washington, Seattle

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00063635 - Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC) | Biotech Hunter | Biotech Hunter